344 related articles for article (PubMed ID: 20177102)
21. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
Yau YY; Chan WS; Tam YM; Vernon P; Wong S; Coel M; Chu SK
J Nucl Med; 2005 Feb; 46(2):283-91. PubMed ID: 15695788
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients.
Plaza MJ; Collado-Mesa F; Bokhoor J; Alperin N; Yepes MM
Breast J; 2014; 20(3):235-42. PubMed ID: 24750508
[TBL] [Abstract][Full Text] [Related]
23. FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma.
Bernstine H; Braun M; Yefremov N; Lamash Y; Carmi R; Stern D; Steinmetz A; Sosna J; Groshar D
Radiology; 2011 Aug; 260(2):503-10. PubMed ID: 21555347
[TBL] [Abstract][Full Text] [Related]
24. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
[TBL] [Abstract][Full Text] [Related]
25. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
[TBL] [Abstract][Full Text] [Related]
26. Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans.
Kanstrup IL; Klausen TL; Bojsen-Møller J; Magnusson P; Zerahn B
Clin Physiol Funct Imaging; 2009 Apr; 29(2):108-13. PubMed ID: 19076727
[TBL] [Abstract][Full Text] [Related]
27. 18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas.
Noda Y; Kanematsu M; Goshima S; Suzui N; Hirose Y; Matsunaga K; Nishibori H; Kondo H; Watanabe H; Kawada H; Kawai N; Tanahashi Y; Bae KT
Eur Radiol; 2015 Oct; 25(10):3009-16. PubMed ID: 25854217
[TBL] [Abstract][Full Text] [Related]
28. Liver SULmean at FDG PET/CT: interreader agreement and impact of placement of volume of interest.
Viner M; Mercier G; Hao F; Malladi A; Subramaniam RM
Radiology; 2013 May; 267(2):596-601. PubMed ID: 23297330
[TBL] [Abstract][Full Text] [Related]
29. Lipomatous hypertrophy of the interatrial septum: prevalence and features on fusion 18F fluorodeoxyglucose positron emission tomography/CT.
Kuester LB; Fischman AJ; Fan CM; Halpern EF; Aquino SL
Chest; 2005 Dec; 128(6):3888-93. PubMed ID: 16354859
[TBL] [Abstract][Full Text] [Related]
30. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience.
Blake MA; Slattery JM; Kalra MK; Halpern EF; Fischman AJ; Mueller PR; Boland GW
Radiology; 2006 Mar; 238(3):970-7. PubMed ID: 16505394
[TBL] [Abstract][Full Text] [Related]
31. Effect of hyperglycemia on brain and liver
Viglianti BL; Wong KK; Wimer SM; Parameswaran A; Nan B; Ky C; Townsend DM; Rubello D; Frey KA; Gross MD
Biomed Pharmacother; 2017 Apr; 88():1038-1045. PubMed ID: 28192877
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy.
Kim JW; Seong J; Yun M; Lee IJ; Yoon HI; Cho HJ; Han KH
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1172-8. PubMed ID: 21570203
[TBL] [Abstract][Full Text] [Related]
33. Test-Retest Variability in Lesion SUV and Lesion SUR in
Hofheinz F; Apostolova I; Oehme L; Kotzerke J; van den Hoff J
J Nucl Med; 2017 Nov; 58(11):1770-1775. PubMed ID: 28473598
[TBL] [Abstract][Full Text] [Related]
34. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
[TBL] [Abstract][Full Text] [Related]
35. Biopsy-proven nonsteatotic liver in adults: estimation of reference range for difference in attenuation between the liver and the spleen at nonenhanced CT.
Park YS; Park SH; Lee SS; Kim DY; Shin YM; Lee W; Lee SG; Yu ES
Radiology; 2011 Mar; 258(3):760-6. PubMed ID: 21212369
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of intrahepatic fat distribution determined by (18)F-FDG PET and CT.
Keramida G; Hunter J; Dizdarevic S; Peters AM
Ann Nucl Med; 2016 Apr; 30(3):200-6. PubMed ID: 26768891
[TBL] [Abstract][Full Text] [Related]
37. The negative impact of fatty liver on maximum standard uptake value of liver on FDG PET.
Lin CY; Lin WY; Lin CC; Shih CM; Jeng LB; Kao CH
Clin Imaging; 2011; 35(6):437-41. PubMed ID: 22040787
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E; Ebied O
Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387
[TBL] [Abstract][Full Text] [Related]
39. Increased metabolic activity in abdominal aortic aneurysm detected by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT).
Kotze CW; Menezes LJ; Endozo R; Groves AM; Ell PJ; Yusuf SW
Eur J Vasc Endovasc Surg; 2009 Jul; 38(1):93-9. PubMed ID: 19217326
[TBL] [Abstract][Full Text] [Related]
40. Effects of Tumor Burden on Reference Tissue Standardized Uptake for PET Imaging: Modification of PERCIST Criteria.
Viglianti BL; Wale DJ; Wong KK; Johnson TD; Ky C; Frey KA; Gross MD
Radiology; 2018 Jun; 287(3):993-1002. PubMed ID: 29558296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
